NEWARK, Calif. (AP) — NEWARK, Calif. (AP) — Protagonist Therapeutics Inc. (PTGX) on Tuesday reported first-quarter net income of $207.3 million.

The Newark, California-based company said it had net income of $3.26 per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $2.51 per share.

The biopharmaceutical company posted revenue of $255 million in the period.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on PTGX at

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News